BGLU24 Antibody

What is BGLU24 and why is it significant for plant research?

BGLU24 is a beta-glucosidase enzyme (AT1G70520, UniProt: Q9LKR7) found in Arabidopsis thaliana that belongs to the glycoside hydrolase family. It plays critical roles in plant defense responses, hormone regulation, and metabolite activation through hydrolysis of glycosidic bonds .

Significance for research:

• Functions in plant secondary metabolite activation

• Involved in defense mechanisms against pathogens

• Participates in hormone signaling pathways

• Contributes to cell wall remodeling during plant development

Unlike commercial overviews, researchers should understand BGLU24's relationship to other beta-glucosidases in the complex family of 47 BGLUs in Arabidopsis, with different expression patterns and substrate specificities across tissues and developmental stages.

How should I validate a BGLU24 antibody before experimental use?

Antibody validation is critical for experimental reproducibility in plant research. Following the "five pillars" approach to antibody validation for BGLU24 provides a comprehensive methodology :

• Genetic strategy validation: Use BGLU24 knockout or knockdown lines as negative controls to confirm specificity. The SALK_208947 Arabidopsis line provides an appropriate control .

• Orthogonal strategy: Compare antibody-based detection with antibody-independent methods such as mass spectrometry or RNA-seq data.

• Independent antibody validation: Test multiple antibodies targeting different epitopes of BGLU24 and compare detection patterns.

• Expression validation: Use recombinant expression systems to overexpress BGLU24 and verify antibody detection sensitivities.

• Immunocapture MS validation: Perform immunoprecipitation followed by mass spectrometry to confirm that the antibody captures the intended protein.

Always document complete antibody information including catalog number, lot number, and dilution ratios used in your specific application to enhance reproducibility .

What are the recommended protocols for using BGLU24 antibody in Western blotting?

For optimal Western blot detection of BGLU24 in Arabidopsis samples:

Protein Extraction Buffer:

• 40 mM Tris-HCl (pH 7.5)

• 200 mM NaCl

• 2 mM EDTA

• 2 mM EGTA

• 2 mM Na₃VO₄

• 2 mM NaF

• 20 mM β-glycerophosphate

• Protease inhibitors (4 mg/ml leupeptin, antipain, aprotinin)

• 0.2% Tween 20

Protocol Steps:

• Homogenize 100 mg plant tissue in liquid nitrogen

• Extract in cold extraction buffer and centrifuge (12,000 rpm, 10 min, 4°C)

• Determine protein concentration (Bradford or BCA)

• Load 25-30 μg protein per lane on 10% SDS-PAGE

• Transfer to PVDF membrane (recommended over nitrocellulose for plant proteins)

• Block with 5% BSA (not milk, which may contain interfering phosphatases)

• Incubate with BGLU24 antibody (1:2000 dilution, 4°C overnight)

• Wash 3× with TBST (10 min each)

• Incubate with HRP-conjugated secondary antibody (1:10,000, 2 hours, RT)

• Detect using chemiluminescent substrate with 30-60s exposure

Expected band size for BGLU24 is approximately 60 kDa, with potential shifts due to post-translational modifications.

How can I detect BGLU24 protein in specific subcellular compartments?

Subcellular fractionation followed by immunoblotting allows precise localization of BGLU24 within plant cells:

Fractionation Protocol:

• Homogenize fresh Arabidopsis tissue using a commercial fractionation kit or differential centrifugation

• Separate cytosolic, ER-enriched, or nuclear fractions using established protocols

• Confirm fraction purity using compartment-specific markers:

  • ER: BiP (Lumenal-binding protein)

  • Cytosol: UGPase (UDP-glucose pyrophosphorylase)

  • Nucleus: Histone H3

  • Plasma membrane: H⁺-ATPase

Table 1: Compartment-Specific Marker Antibodies for Fraction Validation

Specific visualization of BGLU24 can be enhanced using fluorescent-tagged antibodies or confocal microscopy with appropriate negative controls (BGLU24 knockout plants) .

How can I distinguish between BGLU24 and other closely related beta-glucosidases in complex samples?

Distinguishing between BGLU24 and other similar beta-glucosidases in Arabidopsis requires careful consideration of epitope selection and validation:

• Epitope mapping analysis: Select antibodies targeting unique regions of BGLU24 not conserved in related BGLUs (BGLU22, BGLU20, etc.). N-terminal regions often show higher sequence divergence.

• Pre-absorption controls: Pre-incubate the BGLU24 antibody with recombinant BGLU24 protein before immunodetection. A true positive signal should be eliminated by this procedure.

• Cross-reactivity panel: Test BGLU24 antibody against recombinant proteins of closely related BGLUs (particularly BGLU22 and BGLU20) to establish specificity profiles .

• Immunoprecipitation-Mass Spectrometry: Use the antibody to pull down the target protein, then perform MS analysis to confirm identity and detect any cross-reacting proteins .

• Skew-Normal distribution analysis: For quantitative assays, use statistical methods like finite mixture models based on scale mixtures of Skew-Normal distributions to separate signals from closely related antigens .

What are effective approaches to characterize BGLU24 antibody binding kinetics?

Characterizing antibody binding kinetics provides critical information about specificity, affinity, and optimal experimental conditions:

Methodological Approach:

• Surface Plasmon Resonance (SPR):

  • Immobilize purified BGLU24 on a sensor chip

  • Flow antibody at different concentrations over the surface

  • Determine association (kon) and dissociation (koff) rate constants

  • Calculate equilibrium dissociation constant (KD = koff/kon)

• Bio-Layer Interferometry (BLI):

  • Attach biotinylated BGLU24 to streptavidin sensors

  • Measure real-time binding with antibody at multiple concentrations

  • Fit data to determine kon, koff, and KD values

• Enzyme-Linked Immunosorbent Assay (ELISA):

  • Coat plates with BGLU24 or anti-BGLU24

  • Determine binding saturation curves at different antibody concentrations

  • Analyze data using Scatchard plots or non-linear regression

Table 2: Typical Binding Parameters for High-Quality Research Antibodies

Comparing these parameters with antibodies against other plant beta-glucosidases helps determine relative specificity for experimental planning .

How can I use BGLU24 antibody to track enzyme activity changes during plant stress responses?

To effectively monitor BGLU24 activity during plant stress responses:

• Combined protein and activity assays:

  • Quantify BGLU24 protein levels via Western blot using the specific antibody

  • In parallel, measure beta-glucosidase activity using fluorogenic substrates (e.g., 4-methylumbelliferyl-β-D-glucopyranoside)

  • Calculate specific activity (enzyme activity/protein content) to normalize for expression changes

• Time-course experimental design:

  • Sample plants at multiple timepoints after stress application (0, 1, 3, 6, 12, 24, 48 hours)

  • Include appropriate controls (non-stressed plants, BGLU24 knockout plants)

  • Correlate protein levels with enzymatic activity and physiological responses

• Subcellular localization changes:

  • Track changes in BGLU24 localization using subcellular fractionation and immunoblotting

  • Monitor potential redistribution between compartments under stress

  • Correlate with changes in substrate availability in different cellular compartments

A rigorous analysis should include multiple biological replicates and appropriate statistical methods to account for variability in plant stress responses .

How reliable are phospho-specific antibodies for detecting post-translational modifications of BGLU24?

Phospho-specific antibodies require extensive validation for reliable detection of BGLU24 post-translational modifications:

Validation Requirements:

• Antibody specificity: The phospho-specific antibody must recognize only the phosphorylated form of BGLU24 and not the non-phosphorylated form. Validate using:

  • Synthetic phosphorylated and non-phosphorylated peptides

  • BGLU24 protein treated with and without phosphatases

  • Mutated BGLU24 where potential phosphorylation sites are replaced with alanine

• Absorption controls: The antibody should be purified using both:

  • Non-modified peptide (to absorb non-specific antibodies)

  • Modified peptide containing the phosphorylation site

• Detection validation: Confirm phosphorylation status using:

  • Mass spectrometry to verify phosphorylation sites

  • In vitro kinase assays with purified BGLU24

  • Lambda phosphatase treatment to remove phosphate groups as a negative control

• Cross-reactivity assessment: Test against closely related beta-glucosidases with similar phosphorylation motifs

Phospho-specific antibodies typically require 1:1000-1:2000 dilution and overnight incubation at 4°C for optimal results .

What approaches can resolve contradictory results from different BGLU24 antibodies?

When different antibodies targeting BGLU24 produce contradictory results, a systematic troubleshooting approach is essential:

• Epitope mapping: Determine which regions of BGLU24 each antibody recognizes. Antibodies targeting different epitopes may detect different:

  • Conformational states of the protein

  • Splice variants or isoforms

  • Post-translationally modified forms

  • Proteolytic fragments

• Experimental validation panel:

  • Western blotting under reducing and non-reducing conditions

  • Native PAGE to detect conformational dependencies

  • Immunoprecipitation followed by mass spectrometry

  • Detection in wild-type vs. BGLU24 knockout plants

• Antibody characterization table: Create a comprehensive comparison of antibody properties:

Table 3: Comparative Analysis of Different BGLU24 Antibodies

• Independent verification: Use orthogonal methods not dependent on antibodies (e.g., mass spectrometry, activity assays) to resolve contradictions .

How can machine learning approaches enhance BGLU24 antibody design and application?

Machine learning approaches are revolutionizing antibody design and can significantly improve BGLU24 antibody development:

• Epitope prediction and optimization:

  • Use algorithms to identify optimal BGLU24-specific epitopes with maximum antigenicity

  • Predict cross-reactivity with related beta-glucosidases

  • Design epitopes that maintain recognition across experimental conditions

• In silico antibody design:

  • Generate virtual libraries of potential anti-BGLU24 antibodies

  • Screen for predicted affinity, specificity, and developability attributes

  • Design antibodies with >90% humanness for therapeutic applications

• Active learning for experimental design:

  • Implement Hamming Average Distance or Query-by-Committee strategies for epitope testing

  • Reduce experimental testing burden by 35% through computational pre-screening

  • Prioritize experiments with highest information gain potential

• Zero-shot antibody design:

  • Utilize structural prediction models like GaluxDesign to design BGLU24-targeting antibodies

  • Achieve 13-15% success rates in binding prediction (vs. 1.8% with traditional methods)

  • Design CDR loops for specific BGLU24 epitope recognition

Implementation requires collaboration between computational biologists and experimental researchers with integrated feedback loops between in silico prediction and wet-lab validation .

How can I develop an assay to detect naturalizing antibodies against BGLU24 in plant immune response studies?

Developing assays to detect neutralizing antibodies against BGLU24 in plant immune studies requires specialized approaches:

• Enzyme inhibition assay:

  • Purify recombinant BGLU24 with confirmed enzymatic activity

  • Pre-incubate with test antibodies at various concentrations

  • Measure residual enzyme activity using chromogenic/fluorogenic substrates

  • Calculate IC50 values to quantify neutralizing potency

• Competition binding assay:

  • Develop an AlphaLISA-type assay using two antibodies targeting different BGLU24 epitopes

  • Test for interference by potential neutralizing antibodies

  • Measure displacement curves to quantify binding affinity

• Structural characterization:

  • Use X-ray crystallography or cryo-EM to determine antibody binding sites on BGLU24

  • Correlate binding position with enzyme active site accessibility

  • Identify allosteric inhibition mechanisms

• In vivo validation:

  • Test antibody effects on BGLU24-dependent processes in plant models

  • Compare phenotypes with BGLU24 knockout mutants

  • Document physiological consequences of neutralization

When neutralizing activity is detected, examine the structural basis for the inhibition and its relationship to plant defense mechanisms or pathogen interactions .

How do I interpret dynamic antibody responses in studies of plant-pathogen interactions involving BGLU24?

Interpreting dynamic antibody responses in plant-pathogen studies involving BGLU24 requires sophisticated analytical frameworks:

• Temporal profiling approach:

  • Track BGLU24 antibody binding across multiple timepoints post-infection

  • Correlate with pathogen progression, plant defense activation, and disease outcomes

  • Apply seroconversion rate analysis to identify critical response windows

• Statistical analysis using finite mixture models:

  • Apply scale mixtures of Skew-Normal distributions to distinguish antibody populations

  • Use Bayesian Information Criterion (BIC) to determine optimal model fits

  • Identify distinct serological populations in response data

• Multi-parameter measurement panel:

  • Simultaneously assess BGLU24 protein levels, enzyme activity, and substrate availability

  • Monitor related defense enzymes to construct pathway activation profiles

  • Create comprehensive immunological fingerprints of plant responses

• Data analysis framework:

  • Calculate cumulative seroconversion rates and median seroconversion times

  • Develop multi-antigen signatures predictive of infection outcomes

  • Apply receiver operating characteristic (ROC) analysis to identify appropriate thresholds

By applying these methodologies, researchers can move beyond simple presence/absence detection to gain insights into the functional significance of BGLU24 dynamics during plant-pathogen interactions .

What role might BGLU24 antibodies play in investigating protein-protein interactions and condensate formation?

Recent research suggests beta-glucosidases may participate in biomolecular condensates, opening new avenues for BGLU24 research:

• Protein condensate investigation:

  • Use BGLU24 antibodies to track protein distribution during stress responses

  • Detect potential phase separation under molecular crowding conditions

  • Investigate BGLU24 participation in stress granules or processing bodies

• Interactome analysis:

  • Apply proximity labeling techniques (BioID, APEX) with BGLU24 antibodies

  • Conduct co-immunoprecipitation to identify interaction partners

  • Validate interactions using yeast two-hybrid or mammalian two-hybrid systems

• Condensate characterization:

  • Determine if BGLU24 forms homotypic or heterotypic condensates

  • Assess the role of post-translational modifications in condensate regulation

  • Evaluate functional consequences of condensate formation for enzymatic activity

• Methodological approach:

  • Develop fluorescence recovery after photobleaching (FRAP) with labeled BGLU24 antibodies

  • Conduct lattice light-sheet microscopy for real-time visualization

  • Perform in situ proximity ligation assays to validate interactions

This emerging field connects BGLU24 function to cellular organization during stress, potentially revealing new regulatory mechanisms .

How can I develop and validate a phospho-site specific antibody for BGLU24?

Developing a phospho-site specific antibody for BGLU24 requires a systematic approach:

• Target site identification:

  • Use phosphoproteomics data or prediction algorithms to identify likely phosphorylation sites

  • Focus on functionally relevant sites near catalytic residues or regulatory domains

  • Consider conservation among related beta-glucosidases

• Antigen design and antibody production:

  • Design phosphopeptides containing the target site (10-15 amino acids)

  • Include a terminal cysteine for carrier protein conjugation

  • Immunize rabbits with both phosphorylated and non-phosphorylated peptides

• Two-step purification process:

  • First purification: Use non-modified peptide to absorb non-specific antibodies

  • Second purification: Use phosphorylated peptide to capture phospho-specific antibodies

  • Elute and concentrate the final antibody preparation

• Validation protocol:

  • Test antibody against phosphorylated and non-phosphorylated recombinant BGLU24

  • Verify phospho-specificity using lambda phosphatase treatment

  • Confirm using phosphorylation-deficient BGLU24 mutants (Ser/Thr→Ala)

  • Validate in plant extracts with and without phosphatase inhibitors

Expected dilution for Western blotting is typically 1:2000 in 5% BSA, with overnight incubation at 4°C for optimal results .

What approaches can determine if BGLU24 is a target for autoantibodies in plant stress research?

Investigating BGLU24 as a potential autoantibody target requires specialized techniques:

• Multiplex bead assay development:

  • Conjugate purified BGLU24 to fluorescently coded microbeads

  • Include appropriate controls (other BGLUs, unrelated proteins)

  • Screen plant extracts for BGLU24-specific binding

  • Normalize using standard curves from known samples

• Functional assessment:

  • Evaluate antibody-dependent complement deposition (ADCD)

  • Measure potential antibody-dependent cellular cytotoxicity

  • Determine if antibodies enhance or inhibit BGLU24 enzymatic activity

• Epitope mapping:

  • Use peptide arrays covering the BGLU24 sequence to identify binding hotspots

  • Compare epitope profiles across different stress conditions

  • Correlate epitope recognition with functional outcomes

• Statistical analysis:

  • Apply receiver operating characteristic (ROC) analysis to determine optimal thresholds

  • Use finite mixture models to distinguish antibody populations

  • Implement dynamic characteristic analysis for temporal profiling

This approach enables researchers to determine if BGLU24 becomes an autoimmune target during plant stress responses, potentially revealing new mechanisms of plant immune regulation .